A carregar...
Simvastatin is a potential candidate drug in ovarian clear cell carcinomas
Ovarian clear cell carcinomas (OCCC) constitute a rare subtype of epithelial ovarian cancer, lacking efficient treatment options. Based on previous studies, we assessed the anti-proliferative effect of simvastatin, a Rho GTPase interfering drug, in three OCCC cell lines: JHOC-5, OVMANA and TOV-21G,...
Na minha lista:
| Publicado no: | Oncotarget |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Impact Journals LLC
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7546754/ https://ncbi.nlm.nih.gov/pubmed/33088426 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.27747 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|